ACUTE KIDNEY INJURY IN THERAPY WITH ENTECAVIR OR TENOFOVIR FOR CHRONIC HEPATITIS B PATIENTS
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: HUNG, Yi-Chun (Tungs’ Taichung MetroHarbor Hospital, Departments of Pharmacy, Taichung City, China Taiwan)
- Co-author(s): Pei-Liang Chen
Long-term therapy with nucleos(t)ide analogues have been reported with the decline of creatinine clearance for chronic hepatitis B patients.
We retrospectively analyzed the data between October 2006 and December 2014 from 691 chronic hepatitis B patients. The cumulative incidences of acute kidney injury (AKI) were calculated by the Kaplan-Meier.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.